Previous research has established FOXA1's critical role in lung cancer progression, particularly in non-small cell lung cancer (NSCLC), where it enhances proliferation, invasion, migration, and diminishes chemosensitivity20-25. Here, FOXA1 is linked to lung carcinoma.